Minimal Oxygen Supplementation Recommended for Most Inpatients
By HospiMedica International staff writers Posted on 13 Nov 2018 |
A new guidance statement reports that supplemental oxygen is not always indicated for acutely ill patients, and may contribute to higher mortality.
An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. Postoperative, obstetric, and pediatric patients were not included in the review.
The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.
“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”
The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.
Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva
An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. Postoperative, obstetric, and pediatric patients were not included in the review.
The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.
“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”
The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.
Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva
Latest Critical Care News
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
- Noninvasive Double Microbubble Delivery Approach Marks Breakthrough in Brain Cancer Treatment
- Self-Healing Skin-Like Material to Find Applications in Health Monitoring, Surgery and Implants
- Highly-Sensitive Electronic Skin Allows Robots to Feel Heat, Pain and Pressure
- AI-Powered Wearable Sensor Predicts Labor Onset in Pregnant Women
Channels
Surgical Techniques
view channel
Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
Every year, millions of patients receive implantable cardiovascular devices such as arterial and venous catheters, pacemaker leads, artificial hearts, and vascular prostheses. These devices, typically... Read more
First-Ever Technology Makes Blood Translucent During Surgery
No matter the discipline or scale, bleeding is a regular part of any surgery and can create several challenges. In operating room imaging, seeing through blood in real-time during a surgery has been a... Read more
Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
Smith+Nephew (Hull, UK;) has launched its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. It is the only system to now offer trauma surgeons the... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more